M1 (CD86+ CD163-) is a pro-inflammatory phenotype with anti-tumor activity, while M2 (CD86-CD163+) is an immunosuppressive cell type and is thought to have TAMs (tumor-associated macrophage) phenotype in solid tumors that can promote tumor progression [34]. The gene discussed is CD86; the disease is neoplasm.